Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...
The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.
Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with ...
Researchers at the University of Jyväskylä (Finland), in cooperation with national and international research groups, have ...
The incidence of neonatal herpes simplex virus (HSV) infections in the UK and Ireland increased dramatically over 15 years, and outcomes remained poor, with mortality and long-term neurologic ...
A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.
Herpes is one of the most common viral infections in the world, yet it remains widely misunderstood. Caused by the herpes ...
– ABI-5366 is currently being evaluated in ongoing Phase 1b clinical trial with interim proof-of-concept data expected in fall 2025 – SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- ...
The Herpes Hope: How a Modified Virus Is Giving New Options to Patients With Untreatable Skin Cancer
This is read by an automated voice. Please report any issues or inconsistencies here. Cancer-fighting, genetically engineered herpes simplex virus has been shown to be an effective treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results